Academic Journal
View in EDS

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

Bibliographic Details
Title: A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
Authors: Innocent G. Asiimwe, Marc Blockman, Karen Cohen, Clint Cupido, Claire Hutchinson, Barry Jacobson, Mohammed Lamorde, Jennie Morgan, Johannes P. Mouton, Doreen Nakagaayi, Emmy Okello, Elise Schapkaitz, Christine Sekaggya-Wiltshire, Jerome R. Semakula, Catriona Waitt, Eunice J. Zhang, Andrea L. Jorgensen, Munir Pirmohamed
Source: Frontiers in Pharmacology, Vol 13 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: black-African, genome-wide association study, personalized medicine, pharmacokinetics, warfarin, Therapeutics. Pharmacology, RM1-950
More Details: Diversity in pharmacogenomic studies is poor, especially in relation to the inclusion of black African patients. Lack of funding and difficulties in recruitment, together with the requirement for large sample sizes because of the extensive genetic diversity in Africa, are amongst the factors which have hampered pharmacogenomic studies in Africa. Warfarin is widely used in sub-Saharan Africa, but as in other populations, dosing is highly variable due to genetic and non-genetic factors. In order to identify genetic factors determining warfarin response variability, we have conducted a genome-wide association study (GWAS) of plasma concentrations of warfarin enantiomers/metabolites in sub-Saharan black-Africans. This overcomes the issue of non-adherence and may have greater sensitivity at genome-wide level, to identify pharmacokinetic gene variants than focusing on mean weekly dose, the usual end-point used in previous studies. Participants recruited at 12 outpatient sites in Uganda and South Africa on stable warfarin dose were genotyped using the Illumina Infinium H3Africa Consortium Array v2. Imputation was conducted using the 1,000 Genomes Project phase III reference panel. Warfarin/metabolite plasma concentrations were determined by high-performance liquid chromatography with tandem mass spectrometry. Multivariable linear regression was undertaken, with adjustment made for five non-genetic covariates and ten principal components of genetic ancestry. After quality control procedures, 548 participants and 17,268,054 SNPs were retained. CYP2C9*8, CYP2C9*9, CYP2C9*11, and the CYP2C cluster SNP rs12777823 passed the Bonferroni-adjusted replication significance threshold (p < 3.21E-04) for warfarin/metabolite ratios. In an exploratory GWAS analysis, 373 unique SNPs in 13 genes, including CYP2C9*8, passed the Bonferroni-adjusted genome-wide significance threshold (p < 3.846E-9), with 325 (87%, all located on chromosome 10) SNPs being associated with the S-warfarin/R-warfarin outcome (top SNP rs11188082, CYP2C19 intron variant, p = 1.55E-17). Approximately 69% of these SNPs were in linkage disequilibrium (r2 > 0.8) with CYP2C9*8 (n = 216) and rs12777823 (n = 8). Using a pharmacokinetic approach, we have shown that variants other than CYP2C9*2 and CYP2C9*3 are more important in sub-Saharan black-Africans, mainly due to the allele frequencies. In exploratory work, we conducted the first warfarin pharmacokinetics-related GWAS in sub-Saharan Africans and identified novel SNPs that will require external replication and functional characterization before they can be considered for inclusion in warfarin dosing algorithms.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2022.967082/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2022.967082
Access URL: https://doaj.org/article/1b61f543f5f540d0bb36d6daa02e5b11
Accession Number: edsdoj.1b61f543f5f540d0bb36d6daa02e5b11
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16639812&ISBN=&volume=13&issue=&date=20220901&spage=&pages=&title=Frontiers in Pharmacology&atitle=A%20genome-wide%20association%20study%20of%20plasma%20concentrations%20of%20warfarin%20enantiomers%20and%20metabolites%20in%20sub-Saharan%20black-African%20patients&aulast=Innocent%20G.%20Asiimwe&id=DOI:10.3389/fphar.2022.967082
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/1b61f543f5f540d0bb36d6daa02e5b11
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.1b61f543f5f540d0bb36d6daa02e5b11
RelevancyScore: 947
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 947.154418945313
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Innocent+G%2E+Asiimwe%22&quot;&gt;Innocent G. Asiimwe&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Marc+Blockman%22&quot;&gt;Marc Blockman&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Karen+Cohen%22&quot;&gt;Karen Cohen&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Clint+Cupido%22&quot;&gt;Clint Cupido&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Claire+Hutchinson%22&quot;&gt;Claire Hutchinson&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Barry+Jacobson%22&quot;&gt;Barry Jacobson&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mohammed+Lamorde%22&quot;&gt;Mohammed Lamorde&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jennie+Morgan%22&quot;&gt;Jennie Morgan&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Johannes+P%2E+Mouton%22&quot;&gt;Johannes P. Mouton&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Doreen+Nakagaayi%22&quot;&gt;Doreen Nakagaayi&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Emmy+Okello%22&quot;&gt;Emmy Okello&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Elise+Schapkaitz%22&quot;&gt;Elise Schapkaitz&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Christine+Sekaggya-Wiltshire%22&quot;&gt;Christine Sekaggya-Wiltshire&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jerome+R%2E+Semakula%22&quot;&gt;Jerome R. Semakula&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Catriona+Waitt%22&quot;&gt;Catriona Waitt&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Eunice+J%2E+Zhang%22&quot;&gt;Eunice J. Zhang&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Andrea+L%2E+Jorgensen%22&quot;&gt;Andrea L. Jorgensen&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Munir+Pirmohamed%22&quot;&gt;Munir Pirmohamed&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Pharmacology, Vol 13 (2022)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2022.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2022
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Therapeutics. Pharmacology
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22black-African%22&quot;&gt;black-African&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22genome-wide+association+study%22&quot;&gt;genome-wide association study&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22personalized+medicine%22&quot;&gt;personalized medicine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22pharmacokinetics%22&quot;&gt;pharmacokinetics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22warfarin%22&quot;&gt;warfarin&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Therapeutics%2E+Pharmacology%22&quot;&gt;Therapeutics. Pharmacology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22RM1-950%22&quot;&gt;RM1-950&lt;/searchLink&gt;
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Diversity in pharmacogenomic studies is poor, especially in relation to the inclusion of black African patients. Lack of funding and difficulties in recruitment, together with the requirement for large sample sizes because of the extensive genetic diversity in Africa, are amongst the factors which have hampered pharmacogenomic studies in Africa. Warfarin is widely used in sub-Saharan Africa, but as in other populations, dosing is highly variable due to genetic and non-genetic factors. In order to identify genetic factors determining warfarin response variability, we have conducted a genome-wide association study (GWAS) of plasma concentrations of warfarin enantiomers/metabolites in sub-Saharan black-Africans. This overcomes the issue of non-adherence and may have greater sensitivity at genome-wide level, to identify pharmacokinetic gene variants than focusing on mean weekly dose, the usual end-point used in previous studies. Participants recruited at 12 outpatient sites in Uganda and South Africa on stable warfarin dose were genotyped using the Illumina Infinium H3Africa Consortium Array v2. Imputation was conducted using the 1,000 Genomes Project phase III reference panel. Warfarin/metabolite plasma concentrations were determined by high-performance liquid chromatography with tandem mass spectrometry. Multivariable linear regression was undertaken, with adjustment made for five non-genetic covariates and ten principal components of genetic ancestry. After quality control procedures, 548 participants and 17,268,054 SNPs were retained. CYP2C9*8, CYP2C9*9, CYP2C9*11, and the CYP2C cluster SNP rs12777823 passed the Bonferroni-adjusted replication significance threshold (p &lt; 3.21E-04) for warfarin/metabolite ratios. In an exploratory GWAS analysis, 373 unique SNPs in 13 genes, including CYP2C9*8, passed the Bonferroni-adjusted genome-wide significance threshold (p &lt; 3.846E-9), with 325 (87%, all located on chromosome 10) SNPs being associated with the S-warfarin/R-warfarin outcome (top SNP rs11188082, CYP2C19 intron variant, p = 1.55E-17). Approximately 69% of these SNPs were in linkage disequilibrium (r2 &gt; 0.8) with CYP2C9*8 (n = 216) and rs12777823 (n = 8). Using a pharmacokinetic approach, we have shown that variants other than CYP2C9*2 and CYP2C9*3 are more important in sub-Saharan black-Africans, mainly due to the allele frequencies. In exploratory work, we conducted the first warfarin pharmacokinetics-related GWAS in sub-Saharan Africans and identified novel SNPs that will require external replication and functional characterization before they can be considered for inclusion in warfarin dosing algorithms.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1663-9812
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fphar.2022.967082/full; https://doaj.org/toc/1663-9812
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fphar.2022.967082
– Name: URL
  Label: Access URL
  Group: URL
  Data: &lt;link linkTarget=&quot;URL&quot; linkTerm=&quot;https://doaj.org/article/1b61f543f5f540d0bb36d6daa02e5b11&quot; linkWindow=&quot;_blank&quot;&gt;https://doaj.org/article/1b61f543f5f540d0bb36d6daa02e5b11&lt;/link&gt;
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.1b61f543f5f540d0bb36d6daa02e5b11
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.1b61f543f5f540d0bb36d6daa02e5b11
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2022.967082
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: black-African
        Type: general
      – SubjectFull: genome-wide association study
        Type: general
      – SubjectFull: personalized medicine
        Type: general
      – SubjectFull: pharmacokinetics
        Type: general
      – SubjectFull: warfarin
        Type: general
      – SubjectFull: Therapeutics. Pharmacology
        Type: general
      – SubjectFull: RM1-950
        Type: general
    Titles:
      – TitleFull: A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Innocent G. Asiimwe
      – PersonEntity:
          Name:
            NameFull: Marc Blockman
      – PersonEntity:
          Name:
            NameFull: Karen Cohen
      – PersonEntity:
          Name:
            NameFull: Clint Cupido
      – PersonEntity:
          Name:
            NameFull: Claire Hutchinson
      – PersonEntity:
          Name:
            NameFull: Barry Jacobson
      – PersonEntity:
          Name:
            NameFull: Mohammed Lamorde
      – PersonEntity:
          Name:
            NameFull: Jennie Morgan
      – PersonEntity:
          Name:
            NameFull: Johannes P. Mouton
      – PersonEntity:
          Name:
            NameFull: Doreen Nakagaayi
      – PersonEntity:
          Name:
            NameFull: Emmy Okello
      – PersonEntity:
          Name:
            NameFull: Elise Schapkaitz
      – PersonEntity:
          Name:
            NameFull: Christine Sekaggya-Wiltshire
      – PersonEntity:
          Name:
            NameFull: Jerome R. Semakula
      – PersonEntity:
          Name:
            NameFull: Catriona Waitt
      – PersonEntity:
          Name:
            NameFull: Eunice J. Zhang
      – PersonEntity:
          Name:
            NameFull: Andrea L. Jorgensen
      – PersonEntity:
          Name:
            NameFull: Munir Pirmohamed
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 16639812
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in Pharmacology
              Type: main
ResultId 1